GLP-1 vs SGLT2 Inhibitors for Weight Loss: Which Works Better?

If you're exploring medication options for weight loss, you've likely come across two classes of drugs making headlines: GLP-1 receptor agonists and SGLT2 inhibitors. Both were originally developed to treat type 2 diabetes, and both can help with weight loss—but that's where the similarities end.

Understanding the differences between GLP-1 vs SGLT2 inhibitors for weight loss can help you make an informed decision about which approach might work best for your health goals. Let's break down how these medications work, their effectiveness, and what you should know before starting either one.

What Are GLP-1 Receptor Agonists?

GLP-1 receptor agonists are medications that mimic a natural hormone called glucagon-like peptide-1. This hormone plays several important roles in regulating blood sugar and appetite.

Popular GLP-1 medications include Semaglutide (brand names Ozempic and Wegovy) and Tirzepatide (Mounjaro and Zepbound). These medications work by:

• Slowing down how quickly food leaves your stomach
• Reducing appetite and food cravings
• Helping you feel fuller for longer after meals
• Improving insulin production when blood sugar is elevated

The weight loss effect from GLP-1 medications is primarily driven by decreased appetite. Most people naturally eat less because they feel satisfied with smaller portions.

What Are SGLT2 Inhibitors?

SGLT2 inhibitors work through a completely different mechanism. These medications block a protein in your kidneys that normally reabsorbs glucose back into your bloodstream.

Common SGLT2 inhibitors include Jardiance (empagliflozin), Farxiga (dapagliflozin), and Invokana (canagliflozin). By blocking glucose reabsorption, these drugs:

• Cause your body to eliminate excess glucose through urine
• Reduce overall blood sugar levels
• Create a modest calorie deficit (glucose contains calories)
• May have beneficial effects on heart and kidney health

The weight loss from SGLT2 inhibitors happens because you're literally urinating out calories in the form of glucose—typically around 200-300 calories per day.

GLP-1 vs SGLT2 Inhibitors: Weight Loss Effectiveness

When it comes to weight loss results, GLP-1 receptor agonists are significantly more effective than SGLT2 inhibitors.

Clinical studies show that GLP-1 medications can lead to substantial weight loss:

• Semaglutide: Average weight loss of 12-15% of body weight over 68 weeks
• Tirzepatide: Average weight loss of 15-22% of body weight, depending on dose

In contrast, SGLT2 inhibitors produce more modest results:

• Average weight loss of 2-3% of body weight
• Most weight loss occurs in the first 3-6 months
• Effects plateau after initial reduction

If weight loss is your primary goal, GLP-1 medications are clearly the more powerful option. SGLT2 inhibitors are better viewed as diabetes medications with a small weight loss benefit, rather than dedicated weight loss drugs.

Side Effects and Safety Considerations

Both medication classes have different side effect profiles you should know about.

GLP-1 side effects are primarily gastrointestinal and may include:

• Nausea, especially when starting or increasing dose
• Diarrhea or constipation
• Vomiting in some cases
• Reduced appetite (which is also the therapeutic effect)

Most GLP-1 side effects are mild to moderate and improve over time as your body adjusts.

SGLT2 inhibitor side effects are different and may include:

• Increased urination and thirst
• Urinary tract infections
• Yeast infections, particularly in women
• Dehydration if fluid intake isn't adequate
• Rare but serious: diabetic ketoacidosis

Your healthcare provider will consider your complete medical history when recommending either medication class.

Which Is Better for You?

The choice between GLP-1 vs SGLT2 inhibitors for weight loss depends on your individual health situation and goals.

GLP-1 medications may be better if:

• Weight loss is your primary objective
• You want significant, sustained weight reduction
• You struggle with appetite control and portion sizes
• You can manage potential gastrointestinal side effects

SGLT2 inhibitors may be better if:

• You have type 2 diabetes and heart or kidney concerns
• You want modest weight loss as a secondary benefit
• You've had difficulty tolerating GLP-1 medications
• Your doctor recommends them for cardiovascular protection

It's worth noting that some people use both medication classes together under medical supervision, as they work through different mechanisms and can complement each other.

For more information about medication options and weight loss strategies, visit ozarihealth.com/blog for additional resources.

Cost and Accessibility

Both GLP-1 and SGLT2 inhibitors can be expensive, though pricing varies significantly.

Brand-name GLP-1 medications often cost $900-$1,300 per month without insurance. However, compounded versions of Semaglutide and Tirzepatide are available at much lower prices through specialized providers.

SGLT2 inhibitors typically range from $400-$600 per month for brand-name versions, with some generic options becoming available that cost less.

Insurance coverage varies widely for both classes, especially when prescribed for weight loss rather than diabetes.

Key Takeaways

• GLP-1 receptor agonists are significantly more effective for weight loss (12-22% body weight) compared to SGLT2 inhibitors (2-3% body weight)
• GLP-1 medications work by reducing appetite and slowing digestion, while SGLT2 inhibitors eliminate glucose through urine
• GLP-1s are better suited for people prioritizing weight loss; SGLT2 inhibitors offer modest weight reduction alongside heart and kidney benefits for diabetics
• Both medication classes have different side effect profiles and should be chosen based on your individual health needs and medical history

Frequently Asked Questions

Can you take GLP-1 and SGLT2 inhibitors together?

Yes, these medications can be used together under medical supervision since they work through different mechanisms. Some people with type 2 diabetes use both to maximize blood sugar control, weight loss, and cardiovascular benefits. Your healthcare provider can determine if combination therapy is appropriate for your situation.

How long does it take to see weight loss results with each medication?

With GLP-1 medications, most people begin noticing appetite changes within the first week, with measurable weight loss starting within 4-8 weeks. Weight loss continues progressively over several months. SGLT2 inhibitors produce faster initial results, with most weight loss occurring in the first 3-6 months, though the total amount is more modest.

Are GLP-1 or SGLT2 inhibitors FDA-approved for weight loss?

Certain GLP-1 medications are FDA-approved specifically for weight loss, including Wegovy (Semaglutide) and Zepbound (Tirzepatide). SGLT2 inhibitors are not FDA-approved for weight loss as a primary indication—they're approved for type 2 diabetes and certain heart and kidney conditions, with weight loss being a secondary benefit.

At Ozari Health, we offer compounded Semaglutide and Tirzepatide as low as $99/month, prescribed by licensed providers and shipped to your door. Learn more at ozarihealth.com.

Reviewed by the Ozari Clinical Content Team (OCCT) — health writers and wellness professionals specializing in GLP-1 therapy and metabolic health. This content is for informational purposes only and does not constitute medical advice. Always consult a licensed healthcare provider before starting any medication.